| Typicality: | 0.378 |
| Saliency: | 0.225 |
| in their early stage | 3 | temporal |
| in 56 percent of patients | 3 | other |
| by available tests | 2 | other |
| tumor → be → undetectable | 7 |
| tumor → become → undetectable | 5 |
| negative | neutral | positive |
| 0.365 | 0.486 | 0.149 |
| Raw frequency | 12 |
| Normalized frequency | 0.225 |
| Modifier score | 0.600 |
| Perplexity | 33.852 |